Teclistamab in Combination with Subcutaneous Daratumumab and Lenalidomide in Patients with Multiple Myeloma: Results from One Cohort of MajesTEC-2, a Phase1b, Multicohort Study

Autor: Searle, Emma ^*, Quach, Hang, Wong, Sandy W., Costa, Luciano J., Hulin, Cyrille ^*, Janowski, Wojciech ^*, Berdeja, Jesus, Anguille, Sébastien ^*, Matous, Jeffrey V., Touzeau, Cyrille ^*, Michallet, Anne-Sophie ^*, Husnik, Marla ^*, Vishwamitra, Deeksha ^*, Niu, Zhuolu ^*, Larsen, Julie ^*, Chen, Lingling ^*, Goldberg, Jenna D. ^*, Popat, Rakesh ^*, Spencer, Andrew

Publikováno v: In Blood 15 November 2022 140 Supplement 1:394-396

S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC‐2 STUDY.

Autor: Offner, Fritz, Decaux, Olivier, Hulin, Cyrille, Anguille, Sébastien, Sophie Michallet, Anne, Costa, Luciano, Touzeau, Cyrille, Boyd, Kevin, Vishwamitra, Deeksha, Guo, Yue, Niu, Zhuolu, Larsen, Julie, Chen, Lingling, Banerjee, Arnob, Goldberg, Jenna, Matous, Jeffrey

Publikováno v: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p

Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC‐1.

Autor: Cai, Zhen¹ (AUTHOR), Xia, Zhongjun² (AUTHOR), He, Ai‐Li³ (AUTHOR), Dong, Yu‐Jun⁴ (AUTHOR), Wang, Yafei⁵ (AUTHOR), Liao, Aijun⁶ (AUTHOR), Song, Yang⁷ (AUTHOR), Song MM, Juanjuan⁷ (AUTHOR), Uhlar, Clarissa⁷ (AUTHOR), Chastain, Katherine⁷ (AUTHOR), Watkins, Latisha⁷ (AUTHOR), Luo, Xinchao⁷ (AUTHOR), Huang, Lin⁷ (AUTHOR), Niu, Zhuolu⁷ (AUTHOR), Quijano Cardé, Natalia A.⁷ (AUTHOR), Guo, Yue⁷ (AUTHOR), Xu, Hongmei⁷ (AUTHOR), Verona, Raluca I.⁷ (AUTHOR), Zhou, Longen⁷ (AUTHOR), Li, Jingyun⁷ (AUTHOR)

Publikováno v: Cancer (0008543X). Dec2024, p1. 10p. 3 Illustrations, 3 Charts.